Evotec AG: Evotec SE Fiscal Year 2021 Results: 'Setting the

STRONG FINANCIAL RESULTS: 23% INCREASE IN GROUP REVENUES SIGNIFICANTLY EXCEEDING GUIDANCEDATA-DRIVEN PLATFORMS AND TECHNOLOGIES INCREASE PROBABILITIES OF SUCCESS IN ALL MODALITIESSUBSTANTIALLY STRENGTHENED

Related Keywords

Germany , Garonne , France General , France , Eppendorf , Nordrhein Westfalen , Hamburg , United States , Munich , Bayern , United Kingdom , Neuried , Italy , French , Volker Braun , Evotec Biologics , Matthias Evers , Bristol Myers Squibb , Werner Lanthaler , Gabriele Hansen , Evotec Group , Center Hamburg , Linkedin , Evotec Se Frankfurt Stock Exchange , Nasdaq , Head Of Global Corporate Communications Marketing , Us Department Of Defense , Exscientia Ltd , Oxford University , Frankfurt Stock Exchange , Glaxosmithkline Spa , Crowfoot Hodgkin , Campus Neuried , Chief Business Officer , Chinook Therapeutics , Medical Center Hamburg Eppendorf , Kazia Therapeutics , Danube Labs , Eastern Europe , Topas Therapeutics , Bicycle Therapeutics , Related Sciences , Good Manufacturing Practice , Occitanie Region , Chief Executive Officer , Global Corporate Communications , Global Investor Relations , Evotec , Iscal , Ear , 021 , Results , Setting , Race , Data , Riven , Autobahn , Mures ,